FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060883428> ?p ?o ?g. }

• W2060883428 endingPage "489" @default.
• W2060883428 startingPage "485" @default.
• W2060883428 abstract "Allopurinol, a hypouricemic agent, has been shown to present therapeutic effects in mania associated with hyperuricemia. This study assessed the efficacy and safety of risperidone as an adjunctive agent to lithium and haloperidol for the treatment of acute mania in hospitalized bipolar patients.Eighty-two patients aged between 18 and 49 were eligible to participate, as they met the DSM-IV criteria for a current manic episode, on the basis of a clinical interview by two academician psychiatrists. In addition, a score of at least 20 points on the Young Mania Rating Scale was required representing at least a moderate-to-severe mania. Forty-one patients were randomly allocated to lithium (1-1.2 mEq/L) + haloperidol (10 mg/day) + allopurinol (300 mg/day) (group A) or lithium (1-1.2 mEq/L) + haloperidol (10 mg/day) + placebo (group B) for an 8-week, double-blind, placebo-controlled study. Patients were assessed by a third-year resident of psychiatry at baseline and at 7, 14, 28, 42, and 56 days after the medication started. The mean decrease in the Young Mania Rating Scale score from baseline was used as the main outcome measure of response of mania to treatment. The extrapyramidal symptoms were assessed using the Extrapyramidal Symptoms Rating Scale (ESRS). Side effects were systematically recorded throughout the study and were assessed using a checklist.Young Mania Rating Scale scores improved with allopurinol. The difference between the two protocols was significant as indicated by the effect of the group, the between-subjects factor (F = 5.22, df = 1, p = 0.008). The mean ESRS scores for the placebo group were higher than the allopurinol group. However, the differences were not significant over the trial. The difference between the two groups in the frequency of side effects was not significant except for agitation that was more often in the placebo group.The efficacy of allopurinol to obtain a greater improvement in patients with mania seems to support the purinergic dysfunction in mania." @default.
• W2060883428 created "2016-06-24" @default.
• W2060883428 creator A5024753909 @default.
• W2060883428 creator A5058826963 @default.
• W2060883428 creator A5062382837 @default.
• W2060883428 creator A5088810181 @default.
• W2060883428 date "2006-10-01" @default.
• W2060883428 modified "2023-10-10" @default.
• W2060883428 title "Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial" @default.
• W2060883428 cites W1511707795 @default.
• W2060883428 cites W1965552866 @default.
• W2060883428 cites W1971859669 @default.
• W2060883428 cites W1983235175 @default.
• W2060883428 cites W2051389456 @default.
• W2060883428 cites W2053271940 @default.
• W2060883428 cites W2080561657 @default.
• W2060883428 cites W2090784587 @default.
• W2060883428 cites W2124038655 @default.
• W2060883428 cites W2127622391 @default.
• W2060883428 cites W2139410928 @default.
• W2060883428 cites W2151141073 @default.
• W2060883428 cites W2328872480 @default.
• W2060883428 doi "https://doi.org/10.1111/j.1399-5618.2006.00363.x" @default.
• W2060883428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17042886" @default.
• W2060883428 hasPublicationYear "2006" @default.
• W2060883428 type Work @default.
• W2060883428 sameAs 2060883428 @default.
• W2060883428 citedByCount "72" @default.
• W2060883428 countsByYear W20608834282012 @default.
• W2060883428 countsByYear W20608834282013 @default.
• W2060883428 countsByYear W20608834282014 @default.
• W2060883428 countsByYear W20608834282015 @default.
• W2060883428 countsByYear W20608834282016 @default.
• W2060883428 countsByYear W20608834282017 @default.
• W2060883428 countsByYear W20608834282018 @default.
• W2060883428 countsByYear W20608834282019 @default.
• W2060883428 countsByYear W20608834282020 @default.
• W2060883428 countsByYear W20608834282021 @default.
• W2060883428 countsByYear W20608834282022 @default.
• W2060883428 countsByYear W20608834282023 @default.
• W2060883428 crossrefType "journal-article" @default.
• W2060883428 hasAuthorship W2060883428A5024753909 @default.
• W2060883428 hasAuthorship W2060883428A5058826963 @default.
• W2060883428 hasAuthorship W2060883428A5062382837 @default.
• W2060883428 hasAuthorship W2060883428A5088810181 @default.
• W2060883428 hasConcept C118552586 @default.
• W2060883428 hasConcept C126322002 @default.
• W2060883428 hasConcept C138496976 @default.
• W2060883428 hasConcept C142724271 @default.
• W2060883428 hasConcept C15744967 @default.
• W2060883428 hasConcept C168563851 @default.
• W2060883428 hasConcept C204787440 @default.
• W2060883428 hasConcept C27081682 @default.
• W2060883428 hasConcept C2776174506 @default.
• W2060883428 hasConcept C2776412080 @default.
• W2060883428 hasConcept C2776809841 @default.
• W2060883428 hasConcept C2777089681 @default.
• W2060883428 hasConcept C2778541603 @default.
• W2060883428 hasConcept C2780261098 @default.
• W2060883428 hasConcept C2780494398 @default.
• W2060883428 hasConcept C2780616385 @default.
• W2060883428 hasConcept C2780948584 @default.
• W2060883428 hasConcept C513476851 @default.
• W2060883428 hasConcept C71924100 @default.
• W2060883428 hasConcept C83849319 @default.
• W2060883428 hasConceptScore W2060883428C118552586 @default.
• W2060883428 hasConceptScore W2060883428C126322002 @default.
• W2060883428 hasConceptScore W2060883428C138496976 @default.
• W2060883428 hasConceptScore W2060883428C142724271 @default.
• W2060883428 hasConceptScore W2060883428C15744967 @default.
• W2060883428 hasConceptScore W2060883428C168563851 @default.
• W2060883428 hasConceptScore W2060883428C204787440 @default.
• W2060883428 hasConceptScore W2060883428C27081682 @default.
• W2060883428 hasConceptScore W2060883428C2776174506 @default.
• W2060883428 hasConceptScore W2060883428C2776412080 @default.
• W2060883428 hasConceptScore W2060883428C2776809841 @default.
• W2060883428 hasConceptScore W2060883428C2777089681 @default.
• W2060883428 hasConceptScore W2060883428C2778541603 @default.
• W2060883428 hasConceptScore W2060883428C2780261098 @default.
• W2060883428 hasConceptScore W2060883428C2780494398 @default.
• W2060883428 hasConceptScore W2060883428C2780616385 @default.
• W2060883428 hasConceptScore W2060883428C2780948584 @default.
• W2060883428 hasConceptScore W2060883428C513476851 @default.
• W2060883428 hasConceptScore W2060883428C71924100 @default.
• W2060883428 hasConceptScore W2060883428C83849319 @default.
• W2060883428 hasIssue "5p1" @default.
• W2060883428 hasLocation W20608834281 @default.
• W2060883428 hasLocation W20608834282 @default.
• W2060883428 hasOpenAccess W2060883428 @default.
• W2060883428 hasPrimaryLocation W20608834281 @default.
• W2060883428 hasRelatedWork W1964232035 @default.
• W2060883428 hasRelatedWork W2059037058 @default.
• W2060883428 hasRelatedWork W2062147570 @default.
• W2060883428 hasRelatedWork W2062932782 @default.
• W2060883428 hasRelatedWork W2080906317 @default.
• W2060883428 hasRelatedWork W2110964571 @default.
• W2060883428 hasRelatedWork W2126666998 @default.
• W2060883428 hasRelatedWork W2382508582 @default.

• next